Kenji Orihashi
Director/Board Member at FUJIFILM Diosynth Biotechnologies UK Ltd.
Profile
Kenji Orihashi is currently a Director at FUJIFILM Diosynth Biotechnologies UK Ltd.
He was previously a Director at FUJIFILM Diosynth Biotechnologies Texas LLC.
Kenji Orihashi active positions
Companies | Position | Start |
---|---|---|
FUJIFILM Diosynth Biotechnologies UK Ltd.
FUJIFILM Diosynth Biotechnologies UK Ltd. Pharmaceuticals: MajorHealth Technology Part of FUJIFILM Holdings Corp., FUJIFILM Diosynth Biotechnologies UK Ltd. is a pharmaceutical manufacturing company. The company is based in Billingham, UK. The British company was founded in 2006. Lars Petersen has been the CEO of the company since 2023. | Director/Board Member | 2015-02-28 |
Former positions of Kenji Orihashi
Companies | Position | End |
---|---|---|
FUJIFILM Diosynth Biotechnologies Texas LLC
FUJIFILM Diosynth Biotechnologies Texas LLC Pharmaceuticals: OtherHealth Technology Fujifilm Diosynth Biotechnology Texas LLC manufactures and distributes biopharmaceutical vaccines. The company was founded on February 25, 2011 and is headquartered in College Station, TX. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
FUJIFILM Diosynth Biotechnologies Texas LLC
FUJIFILM Diosynth Biotechnologies Texas LLC Pharmaceuticals: OtherHealth Technology Fujifilm Diosynth Biotechnology Texas LLC manufactures and distributes biopharmaceutical vaccines. The company was founded on February 25, 2011 and is headquartered in College Station, TX. | Health Technology |
FUJIFILM Diosynth Biotechnologies UK Ltd.
FUJIFILM Diosynth Biotechnologies UK Ltd. Pharmaceuticals: MajorHealth Technology Part of FUJIFILM Holdings Corp., FUJIFILM Diosynth Biotechnologies UK Ltd. is a pharmaceutical manufacturing company. The company is based in Billingham, UK. The British company was founded in 2006. Lars Petersen has been the CEO of the company since 2023. | Health Technology |
- Stock Market
- Insiders
- Kenji Orihashi